Trials / Completed
CompletedNCT01744860
Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples
Evaluation of Concordance Between the Methods Used in INCa Platforms and the Cobas® 4800 BRAF V600 Mutation Test for Detection of BRAF V600 Mutations in Melanoma in Real Life Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 420 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This non-interventional study will compare the Cobas BRAF V600 mutation assay with in-house methods used in molecular laboratories for the assessment of the BRAF mutation status in melanoma tumor samples. No patients will be enrolled in this study. Data will be collected for approximately 6 months.
Conditions
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2012-12-07
- Last updated
- 2016-03-28
- Results posted
- 2016-03-28
Locations
12 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01744860. Inclusion in this directory is not an endorsement.